Clinical trial

4SCAR-CD44v6 T Cell Therapy Targeting Cancer

NCT04427449

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2026-06-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2026-06-01Date precision: day

Registry last updated2026-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancers Which Are CD44v6 Positiveunresolved

Interventions

CD44v6-specific CAR gene-engineered T cellsBIOLOGICAL

Sponsors & collaborators

Shenzhen Geno-Immune Medical Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04427449 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.